51 Prevalence of secondary prevention medication use in South America 2 Publication Study Design Study population Participation rate Participants characteristics Outcome Risk of bias Smidt, 2009 2 1 2 2 1 8 Souza, 2013 2 1 2 2 1 8 Stockins, 2011 2 2 2 1 1 8 Trivi, 2018 2 1 2 1 2 8 Vesga, 2006 2 1 2 2 1 8 Vianna, 2012 1 2 2 1 2 8 Baptista, 2012 2 1 1 2 1 7 Bohatch, 2015 1 1 2 2 1 7 Brasil, 2013 1 1 2 1 2 7 Breda, 2008 2 1 2 2 0 7 Carvalho, 2007 1 2 2 1 1 7 Castro, 2018 2 0 2 2 1 7 Chaves, 2004 2 1 2 1 1 7 Dayan, 2018 1 1 2 1 2 7 Fernandez, 2009 2 1 2 1 1 7 Finimundi, 2007 2 1 2 0 2 7 Fuchs, 2009 2 1 2 2 0 7 Furuya, 2014 2 1 1 2 1 7 Gambogi, 2009 2 2 0 2 1 7 Gowdak, 2007 2 1 0 2 2 7 Gurfinkel, 2004 2 2 2 1 0 7 Hueb, 2004 2 1 0 2 2 7 Kimura, 2018 2 1 1 2 1 7 Lelys, 2019 2 1 2 1 1 7 Liberato , 2016 2 0 2 2 1 7 Lima-Filho, 2010 2 1 2 1 1 7 Lorenzo, 2014 2 0 2 2 1 7 Neira, 2013 2 1 1 2 1 7 Nery, 2015 1 2 2 1 1 7 Neves, 2012 2 1 2 1 1 7 Noriega, 2008 2 1 2 1 1 7 Pantoni, 2016 2 1 2 1 1 7 Pellegrini, 2014 2 1 2 1 1 7 Pesaro , 2012 2 1 2 1 1 7 Ribeiro , 2015 2 1 2 1 1 7 Rossi, 2014 2 1 1 1 2 7 Silva, 2005 2 0 2 2 1 7 Silveira, 2007 2 1 2 1 1 7 Silveira, 2008 2 0 1 2 2 7 Simon, 2019 2 1 2 1 1 7 Siniawski, 2019 1 1 2 1 2 7 Uchoa, 2015 1 1 2 1 2 7 Vazquez , 2011 1 1 2 1 2 7 Vilar, 2015 2 1 0 2 2 7 Villacorta, 2012 2 0 2 2 1 7 Castillo y Costa, 2018 2 0 0 2 2 6 Chaves, 2019 1 1 1 1 2 6 Cruz, 2009 1 1 2 1 1 6 Feguri, 2017 2 1 2 1 0 6 Fernandes, 2012 2 1 2 1 0 6 Garlet, 2017 1 1 1 1 2 6 Gomes, 2011 2 1 1 2 0 6 Ladeia, 2003 2 0 0 2 2 6 Merchan Villamizarto, 2011 2 1 2 1 0 6 Oliveira, 2019 1 2 2 1 0 6 Rueda-Clausen, 2010 2 0 1 1 2 6 Santos, 2015 2 1 0 1 2 6 Supplemtary File 3 B (Continued).
RkJQdWJsaXNoZXIy MTk4NDMw